Life sciences software & AI news

Daily news on AI, software, and digital tools for pharma, biotech, CROs, and life sciences research labs.

Showing 1000+ results
A dental mirror on a dental chair in a clinic

May 19, 2026

Global Dental Diagnostics and Surgical Equipment Market Expected to Reach US$ 16.86 Billion by 2034 as Advanced Oral Healthcare Technologies Gain Momentum

The global dental diagnostics and surgical equipment market is on a robust growth trajectory, expected to reach approximately $16.86 billion by 2034, driven by advancements in oral healthcare technologies.As reported by Renub Research, the market is anticipated to expand from $9.01 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.21% from 2026 to 2034. This growth is largely attributed to heightened awareness of oral hygiene, an increase in dental disorders, and the rising p
A minimalist representation of financial growth in life sciences software.

May 19, 2026

Veeva Systems stock (US9224171002): Results and cloud growth stay in focus

Veeva Systems is attracting investor interest following its recent earnings report, which highlights key metrics such as subscription growth, operating margins, and forward guidance for its life sciences software offerings.In its latest financial update, Veeva Systems showcased its performance in the life sciences software sector, emphasizing the importance of recurring subscription revenue and margin trends. The company serves a specialized clientele, including drugmakers and regulated life sci
A DNA strand on a lab bench in a dimly lit laboratory

May 19, 2026

Twist Bioscience Corp stock (US90130A1016): biotech shares under pressure despite fresh AI drug disc

Twist Bioscience Corp's stock has recently experienced a downturn despite announcing a promising AI-driven drug discovery partnership with LenioBio, raising questions about the volatility of this biotech player.On May 18, 2026, Twist Bioscience Corp's shares fell approximately 7% to close at $49.17, following a period of strong price increases. This decline occurred shortly after the company revealed its collaboration with LenioBio, aimed at integrating automated DNA manufacturing with AI-led dr
An MRI machine in a dimly lit radiology room with a patient preparing for a scan.

May 19, 2026

Does Q1 Revenue Beat and Narrower Losses Reshape the Bull Case For RadNet’s AI Strategy (RDNT)?

RadNet, Inc. has shown promising financial growth in Q1 2026, reporting a revenue increase to $575.63 million, up from $471.40 million in the previous year, and a reduced net loss of $33.47 million compared to $37.93 million. This revenue growth is attributed to heightened demand for advanced imaging services, strategic acquisitions, and significant investments in AI-driven digital health initiatives aimed at optimizing workflow and capacity. These developments are pivotal as RadNet seeks to ali
A pair of scissors cutting a briefcase silhouette, representing job cuts in pharma.

May 19, 2026

Big pharma cuts jobs and ramps up AI to brace for patent cliff, Korea lags - CHOSUNBIZ

Big pharmaceutical companies are undergoing significant restructuring while increasing their investments in artificial intelligence (AI) to prepare for a looming patent cliff that could impact nearly $400 billion in drug revenues by 2036. This dual strategy includes job cuts and a shift towards AI-driven research and development (R&D) systems to mitigate potential profitability declines.Major players like Takeda, Novo Nordisk, and Merck are at the forefront of this transformation. Takeda recentl
Minimalist illustration of a thymus gland and T-cell

May 19, 2026

Rebuilding The Thymus: AI, Regenerative Medicine, And The Emerging Biotechnology Of Immune Longevity

Recent research is reshaping perceptions of the thymus, suggesting it plays a crucial role in disease susceptibility and immune health throughout adulthood.Traditionally considered less important after childhood, the thymus has now been identified as a significant factor in adult health, particularly in relation to mortality and chronic diseases. A study published in *Nature* indicates that maintaining thymic function in adults correlates with lower risks of various health issues, including canc
3D design model in a dimly lit industrial workspace

May 19, 2026

Dassault Systèmes stock (FR0000130650): Investors watch earnings and software demand

Investors are closely monitoring Dassault Systèmes as it navigates recent trends in software demand and recurring revenue visibility.Dassault Systèmes, a French software company, is attracting interest from investors, particularly those focused on European firms with ties to U.S. industrial and life sciences sectors. The company emphasizes its commitment to long-term software relationships, which is crucial for investors seeking insights into recurring revenue and enterprise spending patterns. I
A caregiver adjusting a health monitoring device in a clinical setting.

May 19, 2026

AI/ML Innovations Inc. Stock Jumps 9% on Healthcare AI Momentum

AI/ML Innovations Inc. has seen a notable 9.09% increase in its stock price, reaching C$0.06, as interest in healthcare AI solutions continues to grow. This spike comes as the company operates within the digital healthcare sector, focusing on personal health monitoring systems designed for caregivers and healthcare professionals.The stock's performance indicates a shift in investor sentiment, as it trades above its 50-day and 200-day moving averages, which suggests positive momentum. However, de
A minimalist illustration of a veterinary syringe and diagnostic test kit in a dark palette.

May 19, 2026

IDEXX Laboratories stock (US45168D1046): fresh Q1 2026 earnings and guidance put diagnostics special

IDEXX Laboratories has released its Q1 2026 earnings report, revealing positive growth and updated financial guidance that underscores its position in the veterinary diagnostics market.The company reported earnings per share (EPS) of $3.47, surpassing analyst expectations of $3.41. This performance aligns with IDEXX's ongoing strategy in the veterinary diagnostics sector, which is primarily driven by its companion animal diagnostics and reference laboratory services. The firm anticipates full-ye
A stethoscope and blood pressure cuff in a clinical setting

May 18, 2026

Cardio Diagnostics Holdings (NASDAQ: CDIO) Offers Broad Suite of AI-Powered Solutions for Cardiovascular Disease Prevention

Cardio Diagnostics Holdings is addressing the critical need for early detection and intervention in cardiovascular disease through a comprehensive suite of AI-powered solutions.Recent research highlights the pressing need for advanced tools that can identify cardiovascular disease (CVD) risks earlier, which is vital for personalized intervention strategies. Cardio Diagnostics Holdings (CDIO) is responding by developing a range of solutions that leverage artificial intelligence, epigenetics, and
A test tube filled with liquid in a medical lab setting.

May 18, 2026

Assessing Tempus AI (TEM) Valuation After Recent Share Price Weakness

Tempus AI, a healthcare technology firm specializing in diagnostics and AI-driven tools, has recently faced significant share price declines, prompting investors to reassess its valuation.Over the past month, Tempus AI (TEM) has experienced a notable downturn, with its stock price dropping 21.4%. This decline contributes to a year-to-date decrease of 29.6%, reflecting broader concerns about the company's profitability despite reported revenue growth. Tempus AI generates approximately $1.36 billi
A minimalist illustration of a pill and capsule representing the pharmaceutical sector.

May 18, 2026

UAE pharma sector poised for strong growth as localisation, AI reshape industry dynamics

The UAE pharmaceutical sector is on the cusp of significant growth, driven by strategic government initiatives, rising healthcare demands, and the integration of advanced technologies like AI.According to industry leaders, including Mansoor Meenai from Arcera, the UAE’s focus on healthcare resilience and local manufacturing has become increasingly vital, especially following pandemic-related disruptions in global supply chains. Local production is not only enhancing supply chain resilience but a